- ￥5300
- GeneTex
- 美国
- GTX83133
- 2025年07月16日
- WB, ELISA
- Mouse
- Human, Rat
企业认证
相关产品推荐更多 >
![SRPX antibody [N3C3]](https://img1.dxycdn.com/2023/0711/255/2344116916935858761-14.jpg!wh200)
![GBP3 antibody [N1C1]](https://img1.dxycdn.com/2023/0516/050/2572066211091928561-14.jpg!wh200)
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Purified recombinant fragment of MYL2 expressed in E. Coli.
- 亚型：
IgG1
- 形态：
Liquid
- 保存条件：
Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
- 克隆性：
Monoclonal
- 标记物：
Unconjugated
- 适应物种：
Human, Rat
- 保质期：
12 months from the shipping date of the product.
- 抗原来源：
Human
- 目录编号：
GTX83133
- 级别：
Primary Antibodies
- 库存：
Available
- 供应商：
GeneTex
- 宿主：
Mouse
- 应用范围：
WB, ELISA
- 靶点：
This antibody detects Myosin light chain 2, slow skeletal/ventricular muscle isoform (MLC-2v) protein.
- 抗体英文名：
Myosin Light Chain 2 (MLC-2v) antibody [7C9]
- 抗体名：
Myosin Light Chain 2 (MLC-2v) 抗体 [7C9]
- 规格：
100 μl
WB analysis of rat fetal heart tissue lysate using GTX83133 Myosin Light Chain 2 antibody [7C9].(Lane 2)
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Labeling Gizzard Myosin with Tetramethylrhodamine Iodoacetamide (Primarily 17kDa Light Chain)
Day 1 Materials 1.50 mM KCl,0.2 mM EGTA,2 mM ATP,2 mM MgCl2,10 mM HEPES,pH 7.0.Need 500 ml. Procedure 1.Thaw appropriate volume of frozen gizzard myosin to obtain 10-20 mg. 2.Centrifuge in a SS34 rotor at 9,000 rpm,4℃ for 20 min. 3.Resuspend
Evaluation of the Cardiac Isoform of 2-Macroglobulin as a Factor Inducing Cardiac Hypertrophy
of cardiac hypertrophy. It was accompanied by enlargement of cardiac myocytes and induction of -myosin heavy chain (MHC) and MLC-2 gene expression. Multiple injections of 182-kDa protein-specific polyclonal antibody into the circulation of aorta-constricted
target Rho-kinase is crucial for spontaneous migration of Walker carcinosarcoma cells. We now show that after treatment of cells with either the Rho inhibitor C3 exoenzyme or the Rho-kinase inhibitor Y-27632, constitutive myosin light chain (MLC
技术资料暂无技术资料 索取技术资料
